Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-12-23

Clinical Trial Update: A Study of SHR-4375 Injection in Combination With Other Antitumor Therapies in Patients With Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for SHR-4375 Injection in combination with other antitumor therapies in patients with advanced solid tumors. The study is in Phase 1 and P…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SHR-4375 Injection

Snippet

Sponsor: Suzhou Suncadia Biopharmaceuticals Co., Ltd. | Conditions: Advanced Solid Tumor | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING